Interchange Capital Partners’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$264K Buy
+4,011
New +$147K 0.04% 354

Other funds holding IDNA

Interchange Capital Partners's IDNA Position: Q3 2026 in Review

Interchange Capital Partners opened a new position in iShares Genomics Immunology and Healthcare ETF (IDNA) in Q3 2026: 4,011 shares worth $264K. The stake represents 0.04% of the portfolio and ranks #354 among its holdings.

81 funds tracked by Wall St. Rank hold IDNA as of Q3 2026.

  • Interchange Capital Partners held 4,011 shares of iShares Genomics Immunology and Healthcare ETF worth $264K as of Q3 2026.
  • iShares Genomics Immunology and Healthcare ETF was a new Interchange Capital Partners position in Q3 2026.
  • iShares Genomics Immunology and Healthcare ETF made up 0.04% of Interchange Capital Partners's portfolio in Q3 2026, its #354 holding.
  • 81 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q3 2026.

Based on Interchange Capital Partners's 13F filing for Q3 2026, filed 28 Oct 2026.